chinese glp-1 💊🧬China has approved the world's first cAMP-biased receptor agonist for type 2 diabetes, developed by Hangzhou-based Sciwind Biosciences. Approved on Jan. 30, Ennoglutide Injection (Xianyida®) is the first Class 1 innovative Rival GLP-1 Weight-Loss Drug Emerges

Advanced glycation end products in the skin: molecular mechanisms, methods of measurement, and inhibitory pathways

Effective management of constipation during GLP-1 therapy involves both preventive strategies and therapeutic interventions

However, the overall impact of genetics appeared to be modest, the researchers said

Additionally, certain antibiotics such as clarithromycin can reduce the concentration of GLP- and/or insulin in the body, making them less effective in managing blood sugar levels

Psychiatry 17 , 664665 (2012)

However, if you dont eat a healthy diet and get regular physical activity, a lot of the weight lost will be muscle